Each year in the US, there are more than ten million patient appointments for treatment of pores and skin infections. Difficile disease, diarrhea or candidiasis, while providing high potency against the required focus on , remarked Nachum Kaplan, Ph.D, Vice President of Microbiology at Affinium. .. Affinium initiates AFN-1252 Phase 2 trial in acute bacterial skin & skin framework infections Affinium Pharmaceuticals announced today dosing of the first individual in a multi-center Phase 2 clinical trial evaluating oral AFN-1252 in acute bacterial skin & pores and skin structure attacks . The Phase 2 study will confirm efficacy and tolerability of 200 mg of oral AFN-1252 dosed twice daily for 5-14 days in patients with staphylococcal skin infections.But she said her team’s findings indicate a shorter-term advantage. ‘We found 3D mammography really does help doctors find more invasive breasts cancers while cutting down on callbacks,’ Friedewald said. A ‘callback’ happens when a mammogram picks up something suspicious, and the physician wants to do additional imaging or a biopsy. For some women, as it happens to be nothing; based on the American Cancer Culture, fewer than ten % of females called back for even more testing are identified as having breast cancer. If 3D mammography can reduce those callbacks, ‘that’s a pretty big offer,’ Pisano said.